The Translational Genomics Research Institute

Oncology & Cancer

FDA approves new therapy for pancreatic cancer patients

Patients with advanced pancreatic cancer now have access to the new FDA approved drug, Onivyde, that produced significant overall survival rates in an international clinical study conducted in part by researchers at HonorHealth ...

Oncology & Cancer

Study provides comprehensive look at brain cancer treatments

Led by the Translational Genomics Research Institute (TGen) and UC San Francisco (UCSF), a comprehensive genetic review of treatment strategies for glioblastoma brain tumors was published today in the Oxford University Press ...

page 3 from 12